Sign In
Buy VIR
$8.66
-0.240 (-2.70%)
At Close: Jul 31, 2026
Coronavirus Mutations: Why The Battle Against Covid Is Just Beginning
07:00am, Friday, 26'th Feb 2021
The battle against Covid-19 is about to get uglier. Coronavirus mutations threaten to undercut a year's worth of work upholding Covid stocks like Pfizer, Moderna and Regeneron Pharmaceuticals.
Glaxo (GSK)/Vir Biotech to Develop Antibodies for Influenza
10:36am, Thursday, 18'th Feb 2021
Glaxo (GSK)/Vir Biotech expands their existing coronavirus collaboration for developing new monoclonal antibody candidates for influenza and other respiratory viruses.
Vir Biotechnology and GlaxoSmithKline Expand Their Partnership
02:20pm, Wednesday, 17'th Feb 2021
The biotech will get $345 million through an upfront payment and equity investment.
Why Vir Biotechnology Stock Is Higher Today
01:00pm, Wednesday, 17'th Feb 2021
The biotech is expanding its collaboration with a big partner.
Vir, GSK ink new R&D deal
08:10am, Wednesday, 17'th Feb 2021
Shares of Vir Biotechnology Inc. were up 12.8% in premarket trading on Wednesday after the company said it would expand its research agreement with GlaxoSmithKline to include the flu and other respira
GSK and Vir Biotechnology Expand Coronavirus Collaboration to Advance New Therapeutics for Influenza and Other Respiratory Viruses
07:04am, Wednesday, 17'th Feb 2021
– Companies applying their combined expertise in immunology and infectious diseases to accelerate the development of promising monoclonal antibody candidates for influenza –
Vir Biotechnology to Provide Corporate Update and Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021
04:01pm, Thursday, 11'th Feb 2021
SAN FRANCISCO, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company will provide a corporate update and report financial results for the fourth quarter a
How Risky Are These Heavily Shorted COVID Stocks?
06:25am, Thursday, 11'th Feb 2021
These biotech companies may be among the winners of the coronavirus treatment race -- if all goes well in clinical trials.
– Scientists continuing to advance critical research on mechanisms of immune evasion exemplified by emerging SARS-CoV-2 variants –
Why Vir Biotechnology Stock Is Skyrocketing Today
01:45pm, Wednesday, 27'th Jan 2021
The company announced some good news regarding one of its COVID-19 programs.
Why Anthem, Frequency Therapeutics And Vir Are Moving Today
12:38pm, Wednesday, 27'th Jan 2021
Vir Biotechnology (NASDAQ: VIR) shares are trading lower Wednesday after JPMorgan downgraded the stock from Neutral to Underweight and announced a price target of $30 per share. Vir Biotechnology is a
INDIANAPOLIS, SAN FRANCISCO and LONDON, Jan. 27, 2021 (GLOBE NEWSWIRE) -- Eli Lilly and Company (NYSE: LLY), Vir Biotechnology, Inc. (NASDAQ: VIR) and GlaxoSmithKline plc (LSE/NYSE: GSK) today announc
Why Vir Biotechnology Stock Skyrocketed Today
05:01pm, Tuesday, 26'th Jan 2021
The immunology specialist is seeking a cure for hepatitis B.
VIR Stock Price Increased 74.32% Today: Why It Happened
04:13pm, Tuesday, 26'th Jan 2021
The stock price of Vir Biotechnology (NASDAQ:VIR) increased by 74.32% today. This is why it happened.
Vir Biotechnology President and CEO explains COVID-19 antibody treatment
03:42pm, Friday, 15'th Jan 2021
#coronavirusvaccine #COVID19vaccine #coronaviruspandemic Vir Biotechnology President and CEO George Scangos discusses antibody treatment and why it is going to be difficult to achieve herd immunity. F
